Medclix Limited

Medclix Limited, based in Morden, UK, is a small, active company founded twelve years ago in 2013. With just two employees and £48,611 in assets, it operates from a virtual address – a fact highlighted by the presence of 246 other companies registered at the same location. The company has three directors but no owners reported, a common situation where one of the directors likely holds the shares.

The company's activities center around retail sales via mail order and internet, as well as operating within the hospital activities industries. Its website, while not providing detailed information, suggests a focus on these sectors. It’s a small company, meeting two of three criteria: turnover less than £10.2 million, balance sheet total less than £5.1 million, and fewer than 50 employees.

Financially, Medclix Limited shows some interesting trends. Cash bank on hand has seen a remarkable surge, increasing by 2100%, reaching £34,000. However, the company’s profit and loss remained steady at £53,000. Trade creditors and corporation tax payable both increased significantly, by 77% each, reaching £31,000. Debtors have also increased, reaching £15,000. Accumulated depreciation impairment property plant equipment increased by 3.9% to £2,500. The number of employees reported has decreased by 50%, down to just one.

The lack of an auditor mentioned, consistent with its status as a small company, means the figures are unaudited. While the company's cash position looks healthy, the increase in liabilities suggests it may be relying on credit to maintain operations. The decrease in employees could be a cost-saving measure, or perhaps a reflection of changing business needs. It's a bit strange that there are no owners reported, but this is not uncommon for small companies.

Registered in England/Wales under the registration number 08356385, with a registered address at SM4 6RW, England, Morden, Marshall House, Suite 21-25 124 Middleton Road.

WARNING:The numbers have been rounded for simplicity and may be inaccurate.Please, refer to the latest financial report for verification.